🎊The Grand Opening of the Rayner Seattle Office🎊 Having acquired #OMIDRIA from Omeros (a Seattle-based company) in December 2021, we’re thrilled to now have an office for our Seattle-based employees 🤸, both current and future.
This achievement symbolises our expansion and commitment to the US market.
-
Rayner Unveils Exciting Enhancements to Digital Platforms at ESCRS 2023, Booth B303
Read More -
Rayner Achieves Milestone Implantations in Landmark Clinical Trials in China and the USA
Read More -
Rayner Achieves Major Milestone With Implantation of 4 Millionth RayOne IOL
Read More -
Rayner Appoints Geoff Allan as Chief Financial Officer
Read More -
Evertreen Partnership
Read More -
Rayner launches ‘Peer2Peer: The Podcast’ for clinical education on the move
Read More